Hope is fading for a Capitol Hill drive to permanently fix Medicare's outdated payment formula and spare doctors from automatic cuts in their fees next month. Now the question is whether lawmakers can regroup and come up ...
Mar 21, 2014
0
0
The Republican-controlled House has voted for the 51st time in 38 months to neuter the nation's health care law.
Mar 15, 2014
0
0
(HealthDay)—The final payment rules for 2014 include a proposal to support care management outside the routine office interaction and policies to promote high quality care and efficiency, according to a report from the ...
Dec 10, 2013
0
0
Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends contributed to ...
Oct 22, 2013
0
0
The full impact of knee replacement surgery on both patients' lives and on society includes significant overall cost savings, according to a new study published in the Journal of Bone and Joint Surgery (JBJS). Researchers ...
Aug 21, 2013
0
0
(HealthDay)—Payments from the Medicare Primary Care Incentive Payment Program (PCIP) were more than $664 million for calendar year 2012, according to a report published by the Centers for Medicare & Medicaid Services (CMS).
Aug 13, 2013
0
0
Even early stages of kidney disease come with steep medical costs, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The study found that expenses related to ...
Aug 1, 2013
0
0
A "geographic value index" that would tie Medicare payment rates to the health benefits and costs of health services in particular regions of the country should not be adopted by Congress, says a new congressionally mandated ...
Jul 24, 2013
0
0
Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.
Jun 18, 2013
0
0
Shareholders of Irish drugmaker Elan Corp. PLC have potentially ended a takeover bid from Royalty Pharma by voting in favor of an Elan share buyback plan.
Jun 17, 2013
0
0
